investor harm

Bronstein, Gewirtz & Grossman files class action against BellRing Brands alleging false sales statements tied to inventory buildup rather than genuine demand.

Alight Inc. faces class action lawsuit alleging executives misled investors about CEO leadership, capital returns, and financial targets from November 2024 to February 2026.

Class action filed against $TCOM alleging false statements about regulatory risks from monopolistic practices. Lead plaintiff deadline set for May 11, 2026.

Class action lawsuit filed against AMC Entertainment over alleged securities violations related to APE preferred equity units. Investors claim material misstatements about distribution rights.

Class action lawsuit filed against Ramaco Resources ($METC) alleging executives made false statements about Brook Mine development progress, covering July-October 2025 investors.

Class action lawsuit filed against $CORP alleging false statements about relacorilant clinical trial strength and FDA approval prospects. Investors from Oct 2024-Dec 2025 urged to participate.

Class action lawsuit filed against Driven Brands Holdings alleging securities fraud, false financial statements, and weak internal controls between May 2023 and February 2026.

Class action lawsuit filed against Nektar Therapeutics alleging executives made false statements about REZOLVE-AA trial enrollment, claiming protocol violations negatively impacted results.

Bronstein, Gewirtz & Grossman LLC filed class action against Gemini Space Station ($GEMI) alleging materially false IPO statements regarding crypto platform viability and international expansion.

Law firm files class action against Kyndryl for alleged securities fraud, false financial statements, and internal control failures affecting investors from August 2024 through February 2026.

Class action lawsuit filed against $UQRR alleging materially false statements about FDA approval and BLA timeline delays. Investors urged to join by April 13, 2026 deadline.

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy development and clinical trials, covering investors from February 2022 through January 2026.

Masonite faces class action alleging it failed to disclose Owens Corning acquisition offers while repurchasing stock at depressed prices from June 2023 to February 2024.

Class action lawsuit filed against $PYPL alleging executives made false statements about revenue projections and 2027 targets under CEO James Chriss.

Class action filed against Picard Medical ($PMI) for alleged securities fraud involving false promotions, insider share dumping, and omitted risk disclosures. Lead plaintiff deadline April 3, 2026.

Class action filed against PomDoctor ($POM) alleging stock fraud through false statements, social media misinformation, and coordinated insider share dumping.

$PLUG faces class action lawsuit alleging false statements about DOE funding and hydrogen production facilities. Investors can seek lead plaintiff status by April 3, 2026.

Class action filed against Lakeland Industries alleging executives misrepresented Pacific Helmets and Jolly business performance while concealing operational issues from December 2023 through December 2025.

Class action lawsuit filed against $AMC alleging securities fraud over APE preferred equity units and undisclosed dividend exclusion loophole.

Class action lawsuit filed against $EOS alleging securities fraud over undisclosed production delays, quality control issues, and inadequate guidance during Nov 2025-Feb 2026 period.